Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

(±)-Enitociclib

Copy Product Info
😃Good
Catalog No. T13467Cas No. 1610358-53-6
Alias (±)-BAY-1251152

(±)-Enitociclib ((±)-BAY-1251152) is a racemic mixture of BAY-1251152, a highly selective inhibitor of PTEF/CDK9.

(±)-Enitociclib

(±)-Enitociclib

Copy Product Info
😃Good
Purity: 99.29%
Catalog No. T13467Alias (±)-BAY-1251152Cas No. 1610358-53-6
(±)-Enitociclib ((±)-BAY-1251152) is a racemic mixture of BAY-1251152, a highly selective inhibitor of PTEF/CDK9.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$31In StockIn Stock
5 mg$81In StockIn Stock
10 mg$123In StockIn Stock
25 mg$228In StockIn Stock
50 mg$372In StockIn Stock
100 mg$596In StockIn Stock
200 mg$847-In Stock
1 mL x 10 mM (in DMSO)$89In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.29%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

(±)-Enitociclib AI Summary
(±)-Enitociclib exhibits potent bioactivity as an inhibitor of CDK9/Cyclin T with an IC50 of 3.0 nM. It also demonstrates significant antiproliferative activity against human MOLM-13 cells with an IC50 of 29.0 nM. The compound shows variable effects on cell viability; it can inhibit or stimulate growth rates in HEK293T cells, while generally enhancing growth in U2OS cells and human fibroblasts. Additionally, in Thermal Shift Assays, (±)-Enitociclib induces changes in melting temperature in various protein domains, suggesting potential interactions that may stabilize those protein regions. This complex bioactivity profile highlights its diverse effects depending on the cellular context..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
(±)-Enitociclib ((±)-BAY-1251152) is a racemic mixture of BAY-1251152, a highly selective inhibitor of PTEF/CDK9.
Synonyms(±)-BAY-1251152
Chemical Properties
Molecular Weight404.43
FormulaC19H18F2N4O2S
Cas No.1610358-53-6
SmilesCOc1cc(F)ccc1-c1cc(Nc2cc(CS(C)(=N)=O)ccn2)ncc1F
Relative Density.1.36 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (123.63 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (6.18 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4726 mL12.3631 mL24.7262 mL123.6308 mL
5 mM0.4945 mL2.4726 mL4.9452 mL24.7262 mL
10 mM0.2473 mL1.2363 mL2.4726 mL12.3631 mL
20 mM0.1236 mL0.6182 mL1.2363 mL6.1815 mL
50 mM0.0495 mL0.2473 mL0.4945 mL2.4726 mL
100 mM0.0247 mL0.1236 mL0.2473 mL1.2363 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (±)-Enitociclib | purchase (±)-Enitociclib | (±)-Enitociclib cost | order (±)-Enitociclib | (±)-Enitociclib chemical structure | (±)-Enitociclib formula | (±)-Enitociclib molecular weight